CLASS II Device recall · Reported 16 Dec 2020 · FDA Enforcement Report

Evolut (TM) PRO+ System recalled by Medtronic Heart Valves

Medtronic Heart Valves Division is recalling Evolut (TM) PRO+ System, distributed nationwide in the US. The recall was initiated on 23 Oct 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll GTINs and associated serial numbers (refer to Attachment A-Product List as of 22-Oct-2020).
Quantity recalled19,961 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0561-2021
FDA event ID
86681
Recalling firm
Medtronic Heart Valves Division, Santa Ana, CA
Classification
Class II
Status
Terminated
Recall initiated
23 Oct 2020
FDA classified
10 Dec 2020
Reported
16 Dec 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

23 Oct 2020Recall initiated by company
10 Dec 2020Classified by FDA+48 days
16 Dec 2020Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Potential for Transcatheter Aortic Valve (TAV) leaflet damage when performing a post-implant balloon dilatation (PID).

Product as listed by the FDA

Evolut (TM) PRO+ System. With the following model numbers: a. EVPROPLUS-23US, Labeled as VLV EVPROPLUS-23US COMM JPN, VLV EVPROPLUS-23 COMM US; b. EVPROPLUS-26US, Labeled as VLV EVPROPLUS-26US COMM JPN, VLV EVPROPLUS-26 COMM US; c. EVPROPLUS-29US, Labeled as VLV EVPROPLUS-29US COMM JPN, VLV EVPROPLUS-29 COMM US; d. EVPROPLUS-34US, Labeled as VLV EVPROPLUS-34 COMM US, VLV EVPROPLUS-34 COMM US SA.

Where it was distributed

Worldwide distribution - U.S. Nationwide distribution and the countries of Panama, Denmark, Austria, Germany, Finland, Sweden, Colombia, India, Mexico, Brazil, Spain, United Kingdom, Australia, Ireland, Italy, Argentina, Japan, Poland, Russian Federation, Hungary, Kazakhstan, Luxembourg, Portugal, Norway, Egypt, Saudi Arabia.

Nationwide

Questions about this recall

Why was it recalled?

Potential for Transcatheter Aortic Valve (TAV) leaflet damage when performing a post-implant balloon dilatation (PID).

Which lots are affected?

All GTINs and associated serial numbers (refer to Attachment A-Product List as of 22-Oct-2020).

Where was it sold?

Worldwide distribution - U.S. Nationwide distribution and the countries of Panama, Denmark, Austria, Germany, Finland, Sweden, Colombia, India, Mexico, Brazil, Spain, United Kingdom, Australia, Ireland, Italy, Argentina, Japan, Poland, Russian Federation, Hungary, Kazakhstan, Luxembourg, Portugal, Norway, Egypt, Saudi Arabia.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

2 other products · FDA event 86681

This product is part of a recall event; the main page for the event is Evolut (TM) PRO System recalled by Medtronic Heart Valves.

More recalls from Medtronic Heart Valves Division

All 7

Other Other Medical Devices recalls

All 13,908